Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer: The CLASS-01 Randomized Clinical Trial.

@article{Yu2019EffectOL,
  title={Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer: The CLASS-01 Randomized Clinical Trial.},
  author={Jiang Yu and Chang-ming Huang and Yi-hong Sun and X. Su and H. Cao and J. Hu and Kuan Wang and J. Suo and K. Tao and Xianli He and Hongbo Wei and M. Ying and W. Hu and Xiaohui Du and Yanfeng Hu and H. Liu and C. Zheng and Ping Li and J. Xie and Fenglin Liu and Ziyu Li and Gang Zhao and Kun Yang and Chunxiao Liu and H. Li and Pingyan Chen and J. Ji and Guoxin Li},
  journal={JAMA},
  year={2019},
  volume={321 20},
  pages={
          1983-1992
        }
}
Importance Laparoscopic distal gastrectomy is accepted as a more effective approach to conventional open distal gastrectomy for early-stage gastric cancer. However, efficacy for locally advanced gastric cancer remains uncertain. Objective To compare 3-year disease-free survival for patients with locally advanced gastric cancer after laparoscopic distal gastrectomy or open distal gastrectomy. Design, Setting, and Patients The study was a noninferiority, open-label, randomized clinical trial… Expand
Long-Term Outcomes of Laparoscopic Distal Gastrectomy for Locally Advanced Gastric Cancer: The KLASS-02-RCT Randomized Clinical Trial.
TLDR
Laroscopic distal gastrectomy with D2 lymphadenectomy was comparable to open surgery in terms of relapse-free survival for patients with locally advanced gastric cancer and could be a potential standard treatment option for locally advanced Gastric cancer. Expand
Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial.
TLDR
This trial supports the non-inferiority of L ADG compared with ODG for clinical stage I gastric cancer relapse-free survival, suggesting that LADG should be considered a standard treatment option when performed by experienced surgeons. Expand
Laparoscopic gastrectomy plus D2 lymphadenectomy is as effective as open surgery in terms of long-term survival: a single-institution study on gastric cancer
TLDR
For patients with gastric cancer, laparoscopic gastrectomy plus D2 lymphadenectomy was not inferior to open surgery in terms of long-term outcomes and positive lymph node ratio (LNR) was a useful prognostic marker for GC patients. Expand
Long-term oncologic result of laparoscopic versus open gastrectomy for gastric cancer: a propensity score matching analysis
TLDR
Laroscopic gastrectomy can be safely applied in both early and locally advanced gastric cancer without compromising oncologic outcomes, and is more frequently performed in the elderly. Expand
Potential survival benefits of open over laparoscopic radical gastrectomy for gastric cancer patients beyond three years after surgery: result from multicenter in-depth analysis based on propensity matching
TLDR
By reducing recurrence, ODG achieves a better survival for GC patients with serous infiltration and tumors larger than 5 cm beyond 3 years after surgery, and can serve as a reference for surgical options and the setting of follow-up time point for clinical studies. Expand
Morbidity and Mortality of Laparoscopic vs Open Total Gastrectomy for Clinical Stage I Gastric Cancer: The CLASS02 Multicenter Randomized Clinical Trial.
TLDR
The results of the CLASS02 trial showed that the safety of LTG with lymphadenectomy by experienced surgeons for clinical stage I gastric cancer was comparable to that of OTG. Expand
Laparoscopic versus open distal gastrectomy for advanced gastric cancer: A meta-analysis of randomized controlled trials and high-quality nonrandomized comparative studies.
TLDR
LDG with D2 lymphadenectomy is a safe and effective technique for patients with AGC when performed by experienced surgeons at high-volume specialized centers. Expand
Laparoscopic gastrectomy for stage II and III advanced gastric cancer: long‑term follow‑up data from a Western multicenter retrospective study
TLDR
It is concluded that LG for AGC is feasible and safe in the general practice of Western institutions when performed by trained surgeons as well as in a real-life Western practice. Expand
Efficacy of minimally invasive distal gastrectomy for elderly patients with clinical stage I/IIA gastric cancer: a propensity-score matched analysis
TLDR
It is found that MIDG showed better efficacy than ODG in elderly gastric cancer patients, and is an acceptable option for elderly patients. Expand
Laparoscopic versus open gastrectomy for serosa-invasive gastric cancer: A single-center retrospective cohort study.
TLDR
Laroscopic gastrectomy is an alternative surgical approach for patients with serosa-invasive gastric cancer in terms of short-term outcomes and long-term survival, and it might be more advantageous for certain populations. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 26 REFERENCES
Effect of Laparoscopic Distal Gastrectomy vs Open Distal Gastrectomy on Long-term Survival Among Patients With Stage I Gastric Cancer: The KLASS-01 Randomized Clinical Trial
TLDR
The KLASS-01 trial revealed similar overall and cancer-specific survival rates between patients receiving laparoscopic and open distal gastrectomy, and confirmed Laparoscopic distal Gastrointestinal Surgery is an oncologically safe alternative to open surgery for stage I gastric cancer. Expand
Decreased Morbidity of Laparoscopic Distal Gastrectomy Compared With Open Distal Gastrectomy for Stage I Gastric Cancer: Short-term Outcomes From a Multicenter Randomized Controlled Trial (KLASS-01).
TLDR
LADG for patients with clinical stage I gastric cancer is safe and has a benefit of lower occurrence of wound complication compared with conventional ODG. Expand
Short-term Outcomes of a Multicenter Randomized Controlled Trial Comparing Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy to Open Distal Gastrectomy for Locally Advanced Gastric Cancer (KLASS-02-RCT).
TLDR
Laroscopic distal gastrectomy with D2 lymphadenectomy for locally advanced gastric cancer shows benefits in terms of lower complication rate, faster recovery, and less pain compared with open surgery. Expand
Laparoscopic Versus Open Subtotal Gastrectomy for Distal Gastric Cancer: Five-Year Results of a Randomized Prospective Trial
TLDR
Laparoscopic radical subtotal gastrectomy for distal gastric cancer is a feasible and safe oncologic procedure with short- and long-term results similar to those obtained with an open approach. Expand
Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial.
TLDR
Experienced surgeons can safely perform LG with D2 lymphadenectomy for AGC, and the morbidity and mortality within 30 days after surgery between the LG and OG groups were compared on the basis of the modified intention-to-treat principle. Expand
Short-term surgical outcomes from a phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer: Japan Clinical Oncology Group Study JCOG0912
TLDR
This trial confirmed that LADG was as safe as ODG in terms of adverse events and short-term clinical outcomes, and may be an alternative procedure in clinical IA/IB gastric cancer if the noninferiority of L ADG in Terms of RFS is confirmed. Expand
Long-term Outcomes of Laparoscopic Versus Open Surgery for Clinical Stage II/III Gastric Cancer: A Multicenter Cohort Study in Japan (LOC-A Study)
TLDR
Evidence is provided to suggest that LG is oncologically comparable to OG for locally advanced gastric cancer, and the validity of this result will be examined in ongoing randomized trials. Expand
A Multi-institutional, Prospective, Phase II Feasibility Study of Laparoscopy-Assisted Distal Gastrectomy with D2 Lymph Node Dissection for Locally Advanced Gastric Cancer (JLSSG0901)
TLDR
The technical safety of LADG with D2 lymph node dissection for locally advanced gastric cancer was demonstrated, and a phase III trial to confirm the non-inferiority of this procedure to open gastrectomy in terms of long-term outcomes is ongoing. Expand
Long-term results of laparoscopic gastrectomy for gastric cancer: a large-scale case-control and case-matched Korean multicenter study.
  • Hyung-Ho Kim, Sang-Uk Han, +7 authors S. Ryu
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2014
TLDR
The long-term oncologic outcomes of laparoscopic gastrectomy for patients with gastric cancer were comparable to those of open gast rectomy in a large-scale, multicenter, retrospective clinical study. Expand
Laparoscopic Versus Open Distal Gastrectomy for Gastric Cancer: A Meta-Analysis of Randomized Controlled Trials and High-Quality Nonrandomized Studies
TLDR
LDG can be performed safely with a shorter hospital stay and fewer complications than open surgery, and lymph node staging appears to be unaffected. Expand
...
1
2
3
...